English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy Journal article
Ling L., Tan S.K., Goh T.H., Cheung E., Nurcombe V., van Wijnen A.J., Cool S.M.. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy[J]. Molecular Cancer, 2015, 14(1).
Authors:  Ling L.;  Tan S.K.;  Goh T.H.;  Cheung E.;  Nurcombe V.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:19  IF:27.7/31.3 | Submit date：2018/12/17
Cell Death  Cell Growth  Heparan Sulfate  Neutralizing Antibody  Targeted Therapy  Tumor  
Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands Journal article
Perkins, SJ, Fung, K. W., Khan, S. Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands[J]. Frontiers in Immunology, 2014, doi:10.3389.fimmu.2014.00126-doi:10.3389.fimmu.2014.00126.
Authors:  Perkins, SJ;  Fung, K. W.;  Khan, S
Favorite |  | Submit date：2023/08/18
Complement system  Factor H  Heparin  Heparan Sulfate